Search for: "PFIZER INCĀ " Results 1061 - 1080 of 1,505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jun 2014, 9:01 pm by Ronald D. Rotunda
Recently, the news reported that Pfizer, Inc. wants to buy a British rival, AstraZeneca, PLC for nearly $100 billion. [read post]
27 Jan 2012, 4:00 am
However, the American company Pfizer Inc., proprietor of the earlier Community trade mark VIAGRA (registered in particular for a drug to treat erectile dysfunction), opposed that application.On the basis on that opposition, OHIM refused to register VIAGUARA as a Community trade mark. [read post]
11 Jan 2024, 12:03 am by Kurt R. Karst
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
17 Sep 2020, 4:55 am by Bob Ambrogi
Apple Inc. (9th Cir. 2020): “Employees receive no compensation for the time spent waiting for and undergoing exit searches, because they must clock out before undergoing a search. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs)   Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs)   Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
6 Nov 2020, 7:16 am by Dennis Crouch
  Mylan is set to merge with Pfizer later this calendar year. [read post]
19 Apr 2022, 5:05 am by David W.S. Lieberman
The Anti-Kickback Statute prohibits offering or accepting kickbacks intended to generate health care business. [read post]
26 Oct 2012, 12:52 pm by Bexis
Pfizer, Inc., No. 2:09-cv-262, 2012 WL 2970627 (D. [read post]
22 Apr 2014, 11:51 am by Dennis Crouch
Those cases are in conflict with a PTAB decision on the same topic: Ex Parte Pfizer, Inc., 2010 WL 532133 (Bd. [read post]